Key Targets of Hormonal Treatment of Prostate Cancer: The Androgen Receptor and 5α-Reductase
July 2009
in “
BJU international
”
Studysummary This review examines the pharmacological properties and potential clinical benefits of 5α‐reductase inhibition in prostate cancer but reports no new research findings.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on bjui-journals.onlinelibrary.wiley.com →